Bipolar disorder, epilepsy
Conditions
Interventions
Patients with psychiatric disorders who have been taking lamotrigine (Lamictal) for at least 2 weeks and have reached steady state will be included in the study and will be treated with the same pharm
Sponsors
Ishizawa Keisuke
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. cases in which LTG was prescribed for the treatment of psychiatric disorders in our psychiatry department 2. cases in which the patient (or a substitute) has given written consent
Exclusion criteria
Exclusion criteria: 1. patients under 18 years of age 2. patients for whom it is impossible to measure LTG blood concentration due to the unavailability of samples necessary for the measurement 3. patients whose consent could not be obtained 4. other patients deemed ineligible by the physician in charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Based on the data obtained, the population pharmacokinetics of lamotrigine in epilepsy patients will be used to estimate trough values, AUC, etc., to evaluate the effect on LTG concentrations in concomitant drugs. | — |
Contacts
Public ContactHiroshi Bando
Tokushima University Hospital
Outcome results
None listed